Form 4: Adma Biologics CFO Receives Stock Grant
Insider Transaction (Form 4)
Terry Kohler, CFO and Treasurer of Adma Biologics, Inc., reported multiple transactions in common stock on July 16, 2026.
Summary
- Grant/award: acquired 85,130 Common Stock on July 16, 2026; holds 143,149 after (Direct).
- Grant/award: acquired 136,363 Stock Option (Right to Buy) on July 16, 2026; holds 136,363 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Terry Kohler — Officer (CFO and Treasurer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-16 | Grant/award | Common Stock | 85,130 | — | — | 143,149 |
| 2026-07-16 | Grant/award | Stock Option (Right to Buy) | 136,363 | — | — | 136,363 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-16 | Grant/award (85,130 shares) |
| 2026-07-16 | Grant/award (136,363 shares) |
Keywords
insider transaction, Form 4, ADMA, ADMA BIOLOGICS, INC., neutral, Terry Kohler
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.